Promising heart drugs ID'd by cutting-edge combo of machine learning, human learning (IMAGE)
Caption
Jeffrey J. Saucerman, PhD, of the University of Virginia’s Department of Biomedical Engineering, and his collaborators have developed a new approach to machine learning – a form of artificial intelligence – to identify drugs that help minimize harmful scarring after a heart attack or other injuries.
Credit
UVA Health
Usage Restrictions
May be used to accompany news coverage of the heart drug identification. All other uses require express written permission from UVA Health.
License
Original content